Skip to content

A clinical trial to study the effect of Dhamargava Ksheerapaka vamana in patients with Polycystic Ovarian Syndrome

Open label single arm clinical study on the effectiveness of vamana with dhamargava ksheerapaka in the management of polycystic ovarian syndrome - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057388
Enrollment
30
Registered
2023-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

None listed

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group of females ranging from 18-45 year 2.Patients fulfilling diagnostic criteria and fit for Vamana Karma 3.Subjects willing to participate in the study and sign the written consent.

Exclusion criteria

Exclusion criteria: 1.Subjects having diabetes mellitus, hypertension, thyroid dysfunction, hyperprolactinemia. 2.Subject having gross structural abnormalities of uterus and appendages of reproductive organs 3.Subjects with fibroid uterus, benign and malignant tumors of reproductive organs 4.Pregnant and lactating subjects

Design outcomes

Primary

MeasureTime frame
Number of vamana vegas during procedur Timepoint: One hour during vamana karma

Secondary

MeasureTime frame
1.Samyaka vamana lakshana 2.Duration of menstrual flow Duration of bleeding after Vamana 1 menstrual cycle Timepoint: 1 month

Countries

India

Contacts

Public ContactDr Ashvini Kumar M

Sri Dharamshala Manjunatheshwara College of Ayurveda and Hospital

ashvinipanchakarma@gmail.com9448705659

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026